vs

Side-by-side financial comparison of IRIDEX CORP (IRIX) and Investar Holding Corp (ISTR). Click either name above to swap in a different company.

Investar Holding Corp is the larger business by last-quarter revenue ($23.5M vs $14.7M, roughly 1.6× IRIDEX CORP). On growth, Investar Holding Corp posted the faster year-over-year revenue change (0.9% vs -69.7%). Over the past eight quarters, IRIDEX CORP's revenue compounded faster (11.9% CAGR vs 4.9%).

IRIDEX Corporation is a global medical technology company that designs, manufactures and distributes advanced laser-based medical devices, primarily serving the ophthalmology and aesthetic medicine sectors. It supplies products to healthcare providers, clinics and medical facilities across North America, Europe, Asia Pacific and other regions, delivering minimally invasive solutions for eye disease treatment and cosmetic procedures.

Investar Holding Corp is a U.S.-headquartered bank holding company that primarily operates across the Gulf Coast region. It delivers a full range of commercial and retail banking services, including deposit products, consumer and business loans, mortgage services, and wealth management solutions for individual clients, small and medium-sized enterprises, and commercial entities.

IRIX vs ISTR — Head-to-Head

Bigger by revenue
ISTR
ISTR
1.6× larger
ISTR
$23.5M
$14.7M
IRIX
Growing faster (revenue YoY)
ISTR
ISTR
+70.6% gap
ISTR
0.9%
-69.7%
IRIX
Faster 2-yr revenue CAGR
IRIX
IRIX
Annualised
IRIX
11.9%
4.9%
ISTR

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
IRIX
IRIX
ISTR
ISTR
Revenue
$14.7M
$23.5M
Net Profit
Gross Margin
37.2%
Operating Margin
30.9%
Net Margin
Revenue YoY
-69.7%
0.9%
Net Profit YoY
EPS (diluted)
$0.50

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IRIX
IRIX
ISTR
ISTR
Q4 25
$14.7M
$23.5M
Q3 25
$12.5M
$24.1M
Q2 25
$13.6M
$22.3M
Q1 25
$11.9M
$24.0M
Q4 24
$12.7M
$23.3M
Q3 24
$11.6M
$22.3M
Q2 24
$12.6M
$20.4M
Q1 24
$11.8M
$21.4M
Net Profit
IRIX
IRIX
ISTR
ISTR
Q4 25
Q3 25
$-1.6M
$6.2M
Q2 25
$-994.0K
$4.5M
Q1 25
$-1.7M
$6.3M
Q4 24
$-834.0K
Q3 24
$-1.9M
$5.4M
Q2 24
$-2.7M
$4.1M
Q1 24
$-3.5M
$4.7M
Gross Margin
IRIX
IRIX
ISTR
ISTR
Q4 25
37.2%
Q3 25
32.1%
Q2 25
34.5%
Q1 25
42.5%
Q4 24
44.0%
Q3 24
37.3%
Q2 24
40.7%
Q1 24
37.9%
Operating Margin
IRIX
IRIX
ISTR
ISTR
Q4 25
30.9%
Q3 25
-11.3%
31.0%
Q2 25
-6.9%
24.4%
Q1 25
-1.7%
32.2%
Q4 24
-3.9%
31.1%
Q3 24
-16.1%
27.6%
Q2 24
-20.9%
24.0%
Q1 24
-28.0%
28.5%
Net Margin
IRIX
IRIX
ISTR
ISTR
Q4 25
Q3 25
-12.6%
25.6%
Q2 25
-7.3%
20.2%
Q1 25
-14.2%
26.3%
Q4 24
-6.6%
Q3 24
-16.7%
24.1%
Q2 24
-21.2%
19.9%
Q1 24
-29.5%
22.0%
EPS (diluted)
IRIX
IRIX
ISTR
ISTR
Q4 25
$0.50
Q3 25
$-0.09
$0.54
Q2 25
$-0.06
$0.46
Q1 25
$-0.10
$0.63
Q4 24
$-0.05
$0.61
Q3 24
$-0.12
$0.54
Q2 24
$-0.16
$0.41
Q1 24
$-0.21
$0.48

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IRIX
IRIX
ISTR
ISTR
Cash + ST InvestmentsLiquidity on hand
$6.0M
Total DebtLower is stronger
$9.8M
Stockholders' EquityBook value
$301.1M
Total Assets
$29.2M
$2.8B
Debt / EquityLower = less leverage
0.03×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IRIX
IRIX
ISTR
ISTR
Q4 25
$6.0M
Q3 25
$5.6M
Q2 25
$6.8M
Q1 25
$7.2M
Q4 24
$2.4M
Q3 24
$3.9M
Q2 24
$4.1M
Q1 24
$5.4M
Total Debt
IRIX
IRIX
ISTR
ISTR
Q4 25
$9.8M
Q3 25
Q2 25
Q1 25
Q4 24
$1.0M
$9.8M
Q3 24
$1.4M
Q2 24
Q1 24
Stockholders' Equity
IRIX
IRIX
ISTR
ISTR
Q4 25
$301.1M
Q3 25
$4.7M
$295.3M
Q2 25
$6.1M
$255.9M
Q1 25
$852.0K
$251.7M
Q4 24
$2.1M
$241.3M
Q3 24
$2.6M
$245.5M
Q2 24
$4.2M
$230.2M
Q1 24
$6.5M
$227.0M
Total Assets
IRIX
IRIX
ISTR
ISTR
Q4 25
$29.2M
$2.8B
Q3 25
$28.4M
$2.8B
Q2 25
$31.6M
$2.7B
Q1 25
$34.2M
$2.7B
Q4 24
$29.1M
$2.7B
Q3 24
$30.2M
$2.8B
Q2 24
$31.2M
$2.8B
Q1 24
$34.1M
$2.8B
Debt / Equity
IRIX
IRIX
ISTR
ISTR
Q4 25
0.03×
Q3 25
Q2 25
Q1 25
Q4 24
0.48×
0.04×
Q3 24
0.53×
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IRIX
IRIX
ISTR
ISTR
Operating Cash FlowLast quarter
$18.2M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IRIX
IRIX
ISTR
ISTR
Q4 25
$18.2M
Q3 25
$-1.2M
$6.9M
Q2 25
$-397.0K
$3.2M
Q1 25
$-1.1M
$4.5M
Q4 24
$-1.2M
$15.9M
Q3 24
$-3.1M
$5.6M
Q2 24
$-1.3M
$2.8M
Q1 24
$-1.6M
$7.8M
Free Cash Flow
IRIX
IRIX
ISTR
ISTR
Q4 25
Q3 25
$-1.2M
Q2 25
$-410.0K
Q1 25
$-1.2M
Q4 24
$-1.2M
Q3 24
$-3.1M
Q2 24
Q1 24
$-1.7M
FCF Margin
IRIX
IRIX
ISTR
ISTR
Q4 25
Q3 25
-9.4%
Q2 25
-3.0%
Q1 25
-9.8%
Q4 24
-9.8%
Q3 24
-26.5%
Q2 24
Q1 24
-14.0%
Capex Intensity
IRIX
IRIX
ISTR
ISTR
Q4 25
Q3 25
0.1%
Q2 25
0.1%
Q1 25
0.1%
Q4 24
0.1%
Q3 24
0.0%
Q2 24
0.0%
Q1 24
0.0%
Cash Conversion
IRIX
IRIX
ISTR
ISTR
Q4 25
Q3 25
1.12×
Q2 25
0.71×
Q1 25
0.71×
Q4 24
Q3 24
1.03×
Q2 24
0.70×
Q1 24
1.66×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons